Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells

European Journal of Cell Biology

Volumn 88, Issue 3, 2009, Pages 181-191

  Yu, Mingxia ^a   Shi, Wenfang ^a   Zhang, Jian ^a   Niu, Lin ^a   Chen, Qizheng ^a   Yan, Dan ^a   Liu, Tao ^a   Jing, Wang ^a   Jiang, Xiaodan ^a   Wei, Feng ^a   Yin, Bingjiao ^a   Zhang, Wenjie ^a   Li, Qingfen ^a   Li, Zhuoya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cytotoxicity; Membrane TNF ; NK cell; Reverse signal

Indexed keywords

FAS LIGAND; GRANZYME B; INTERLEUKIN 2; MESSENGER RNA; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL LINE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TUMOR IMMUNITY;

CELL DEATH; CELL LINE; CELL MEMBRANE; EXOCYTOSIS; FAS LIGAND PROTEIN; GRANZYMES; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; PERFORIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SECRETORY VESICLES; SIGNAL TRANSDUCTION; SOLUBILITY; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 58349103882     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2008.09.001     Document Type: Article

References (43)

1. Aubry J.P., Blaecke A., Lecoanet-Henchoz S., Jeannin P., Herbault N., Caron G., Moine V., and Bonnefoy J.Y. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 37 (1999) 197-204
2. Baxevanis C.N., Voutsas I.F., Tsitsilonis O.E., Tsiatas M.L., Gritzapis A.D., and Papamichail M. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice. Eur. J. Immunol. 30 (2000) 1957-1966
3. Bonnema J.D., Rivlin K.A., Ting A.T., Schoon R.A., Abraham R.T., and Leibson P.J. Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J. Immunol. 152 (1994) 2098-2104
4. Brozovic S., Sahoo R., Barve S., Shiba H., Uriarte S., Blumberg R.S., and Kinane D.F. Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkappaB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. Microbiology 152 (2006) 797-806
5. Caraux A., Kim N., Bell S.E., Zompi S., Ranson T., Lesjean-Pottier S., Garcia-Ojeda M.E., Turner M., and Colucci F. Phospholipase C-{gamma}2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107 (2006) 994-1002
6. Caron G., Delneste Y., Aubry J.P., Magistrelli G., Herbault N., Blaecke A., Meager A., Bonnefoy J.Y., and Jeannin P. Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity. Eur. J. Immunol. 29 (1999) 3588-3595
7. Chen N.J., Huang M.W., and Hsieh S.L. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 166 (2001) 270-276
8. Domonkos A., Udvardy A., Laszlo L., Nagy T., and Duda E. Receptor-like properties of the 26 kDa transmembrane form of TNF. Eur. Cytokine Netw. 12 (2001) 411-419
9. Eissner G., Kohlhuber F., Grell M., Ueffing M., Scheurich P., Hieke A., Multhoff G., Bornkamm G.W., and Holler E. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86 (1995) 4184-4193
10. Eissner G., Kirchner S., Lindner H., Kolch W., Janosch P., Grell M., Scheurich P., Andreesen R., and Holler E. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 164 (2000) 6193-6198
11. Eissner G., Kolch W., and Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 15 (2004) 353-366
12. Ferran C., Dautry F., Merite S., Sheehan K., Schreiber R., Grau G., Bach J.F., and Chatenoud L. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J. Clin. Invest. 93 (1994) 2189-2196
13. Gong J.H., Maki G., and Klingemann H.G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8 (1994) 652-658
14. Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 (1995) 793-802
15. Harashima S., Horiuchi T., Hatta N., Morita C., Higuchi M., Sawabe T., Tsukamoto H., Tahira T., Hayashi K., Fujita S., and Niho Y. Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J. Immunol. 166 (2001) 130-136
16. Higuchi M., Nagasawa K., Horiuchi T., Oike M., Ito Y., Yasukawa M., and Niho Y. Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation - characterization of membrane TNF-alpha. Clin. Immunol. Immunopathol. 82 (1997) 133-140
17. Hube F., and Hauner H. The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture. Endocrinology 141 (2000) 2582-2588
18. Kashii Y., Giorda R., Herberman R.B., Whiteside T.L., and Vujanovic N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol. 163 (1999) 5358-5366
19. Kirchner S., Boldt S., Kolch W., Haffner S., Kazak S., Janosch P., Holler E., Andreesen R., and Eissner G. LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. J. Leukoc. Biol. 75 (2004) 324-331
20. Kirchner S., Holler E., Haffner S., Andreesen R., and Eissner G. Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. Cytokine 28 (2004) 67-74
21. Kizaki M., Sakashita A., Karmakar A., Lin C.W., and Koeffler H.P. Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood 82 (1993) 1142-1150
22. Koga T., Harada H., Shi T.S., Okada S., Suico M.A., Shuto T., and Kai H. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression. Biochem. Biophys. Res. Commun. 337 (2005) 1319-1323
23. Kuo P.-L. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-[alpha]- and interleukin-1[beta]-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. Life Sci. 77 (2005) 2964-2976
24. Li Q., Li L., Shi W., Jiang X., Xu Y., Gong F., Zhou M., Edwards III C.K., and Li Z. Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo. Cancer Immunol. Immunother. 55 (2006) 1470-1479
25. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 25 (2001) 402-408
26. Macdonald A.J., Pick J., Bissonnette E.Y., and Befus A.D. Rat mucosal mast cells: the cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo. Immunology 93 (1998) 533-539
27. Maki G., Klingemann H.G., Martinson J.A., and Tam Y.K. Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J. Hematother. Stem Cell Res. 10 (2001) 369-383
28. Mitoma H., Horiuchi T., Hatta N., Tsukamoto H., Harashima S., Kikuchi Y., Otsuka J., Okamura S., Fujita S., and Harada M. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128 (2005) 376-392
29. Munker R., Marini F., Jiang S., Savary C., Owen-Schaub L., and Andreeff M. Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing. Hematol. Cell Ther. 39 (1997) 75-78
30. Oshimi Y., Oda S., Honda Y., Nagata S., and Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157 (1996) 2909-2915
31. Panyi G., Vamosi G., Bacso Z., Bagdany M., Bodnar A., Varga Z., Gaspar R., Matyus L., and Damjanovich S. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. USA 101 (2004) 1285-1290
32. Piriou L., Chilmonczyk S., Genetet N., and Albina E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 41 (2000) 289-297
33. Pocsik E., Duda E., and Wallach D. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J. Inflamm. 45 (1995) 152-160
34. Ringheanu M., Daum F., Markowitz J., Levine J., Katz S., Lin X., and Silver J. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease. Inflamm. Bowel Dis. 10 (2004) 801-810
35. Shi W.F., Yin B.J., Xiong P., Gong F.L., and Li Z.Y. Relationship between cytotoxicity of two types of TNF-alpha and intracellular free calcium concentration in target cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 20 (2004) 537-539
36. Tsuboi M., Kawakami A., Nakashima T., Matsuoka N., Urayama S., Kawabe Y., Fujiyama K., Kiriyama T., Aoyagi T., Maeda K., and Eguchi K. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J. Lab. Clin. Med. 134 (1999) 222-231
37. Waetzig G.H., Rosenstiel P., Arlt A., Till A., Brautigam K., Schafer H., Rose-John S., Seegert D., and Schreiber S. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J. 19 (2005) 91-93
38. Watts A.D., Hunt N.H., Wanigasekara Y., Bloomfield G., Wallach D., Roufogalis B.D., and Chaudhri G. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in reverse signalling. EMBO J. 18 (1999) 2119-2126
39. Xin L., Wang J., Zhang H., Shi W., Yu M., Li Q., Jiang X., Gong F., Gardner K., Li Q.Q., and Li Z. Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated reverse signaling. Int. J. Mol. Med. 18 (2006) 885-892
40. Yao P.L., Lin Y.C., Sawhney P., and Richburg J.H. Transcriptional regulation of FasL expression and participation of sTNF-alpha in response to Sertoli cell injury. J. Biol. Chem. 282 (2007) 5420-5431
41. Zagury D., Maziere J.C., Morgan D.A., Fouchard M., and Hosli P. Polyenzymatic activation of cellular hydrolases induced by interferon: its role in cell lysis and other interferon-related phenomena. Biomedicine 34 (1981) 82-88
42. Zamai L., Ahmad M., Bennett I.M., Azzoni L., Alnemri E.S., and Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188 (1998) 2375-2380
43. Zhang H., Yan D., Shi X., Liang H., Pang Y., Qin N., Chen H., Wang J., Yin B., Jiang X., Feng W., Zhang W., Zhou M., and Li Z. Transmembrane TNF-{alpha} mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-{kappa}B pathway in Raji Burkitt lymphoma cells. J. Leukoc. Biol. 84 (2008) 789-797